Literature DB >> 32865328

Breaking the deadlock of calcified coronary artery lesions: A contemporary review.

Lampson M Fan1, David Tong2, Gary S Mintz3, Mamas A Mamas4, Ahmed Javed2.   

Abstract

Percutaneous coronary intervention (PCI) of severely calcified lesions is known to result in lower procedural success rates, higher complication rates, and worse long-term clinical outcomes compared to noncalcified lesions. Adequate lesion preparation through calcium modification is crucial in ensuring procedural success and reducing adverse cardiovascular outcomes. There are numerous calcium modification devices currently available whose usefulness depends on the nature of the calcific disease and its anatomical distribution. It can be challenging for the interventionists to decide which device is best suited for their patient. There is also emerging evidence for intravascular imaging in guiding selection of calcium modification devices using parameters such as calcium distribution and depth that directly impact on procedural success and clinical outcomes. In this review we aim to discuss the pathophysiology of coronary calcification, evaluate strategies and technologies of calcium modification and propose an A-M-A-S-A algorithm in managing calcified coronary lesions.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  atherectomy; calcified lesion; intracoronary imaging

Year:  2020        PMID: 32865328     DOI: 10.1002/ccd.29221

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Bail-out therapy in ST-segment elevation myocardial infarction due to calcified lesion causing stent underexpansion: Intravascular lithotripsy is in the lead.

Authors:  Thomas Baudinet; Benjamin Seguy; Laura Cetran; Muhammad Khaled Luttoo; Pierre Coste; Edouard Gerbaud
Journal:  J Cardiol Cases       Date:  2021-01-09

2.  Impact of nodular calcification in patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI).

Authors:  Abigail Demuyakor; Sining Hu; Ekaterina Koniaeva; Minghao Liu; Ziqian Weng; Chen Zhao; Xue Feng; Luping He; Yishuo Xu; Ming Zeng; Wei Meng; Yanli Sun; Boling Yi; Zhanqun Gao; Yuhan Qin; Haibo Jia; Gary S Mintz; Bo Yu
Journal:  BMC Cardiovasc Disord       Date:  2022-03-14       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.